Barclay ML, Kirkpatrick CMJ, Begg EJ. Once-daily aminoglycoside therapy: is it less toxic than multiple daily doses and how should it be monitored? Clin Pharmacokinet 1999; 36: 89–98 ArticlePubMedCAS Google Scholar
Barclay ML, Begg EJ, Chambers ST. Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrob Agents Chemother 1992; 36: 1951–7 ArticlePubMedCAS Google Scholar
Daikos GL, Jackson GG, Lolans VT, et al. Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. J Infect Dis 1990; 162: 414–20 ArticlePubMedCAS Google Scholar
Karlowsky JA, Saunders M, Harding GAJ, et al. In vitro characterisation of aminoglycoside adaptive resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996; 40: 1387–93 PubMedCAS Google Scholar
Korvick JA, Yu VL. Antimicrobial agent therapy for Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991; 35: 2167–72 ArticlePubMedCAS Google Scholar
Gould IM, Milne K, Jason C. Concentration-dependent bacterial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamicin. Drugs Exp Clin Res 1990; 16(12): 621–8 PubMedCAS Google Scholar
Gould IM, Milne K, Harvey G, et al. Ionic binding, adaptive resistance and post-antibiotic effect of netilmicin and ciprofloxacin. J Antimicrob Chemother 1991; 27: 741–8 ArticlePubMedCAS Google Scholar
Chamberland S, Malouin F, Rabin HR, et al. Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency. J Antimicrob Chemother 1990; 25: 995–1010 ArticlePubMedCAS Google Scholar
Gilleland LB, Gilleland HE, Gibson JA, et al. Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa. J Med Microbiol 1989; 29: 41–50 ArticlePubMedCAS Google Scholar
Bodey GP, Middleman E, Umsawadi T, et al. Intravenous gentamicin therapy for infections in patients with cancer. J Infect Dis 1971; Suppl. 124: S174-9
Jackson GG, Riff L_J. Pseudomonas bacteremia_: pharmacologic and other bases for failure of treatment with gentamicin. J Infect Dis 1971; 124 Suppl.: S185–91 ArticlePubMed Google Scholar
Xiong YQ, Caillon J, Drugeon H, et al. The effect of rifampicin on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides. J Antimicrob Chemother 1996; 37: 993–8 ArticlePubMedCAS Google Scholar
Barclay ML. Studies to optimise dosage regimens for aminoglycoside and other antibiotics [MD thesis]. Dunedin (NZ): University of Otago, 1995: 50–7 Google Scholar
Barclay ML, Begg EJ, Chambers ST. The effect of aminoglycoside-induced adaptive resistance on the antibacterial activity of other antibiotics against Pseudomonas aeruginosa in vitro. J Antimicrob Chemother 1996; 38: 853–8 ArticlePubMedCAS Google Scholar
Daikos GL, Lolans VT, Jackson GG. First-exposure adaptive resistance to aminoglycosides in vivo with meaning for optimal clinical use. Antimicrob Agents Chemother 1991; 35: 117–23 ArticlePubMedCAS Google Scholar
Xiong Y-A, Caillon J, Kergueris MF, et al. Adaptive resistance of Pseudomonas aeruginosa and killing kinetics in a rabbit endocarditis model. Antimicrob Agents Chemother 1997; 41: 823–6 PubMedCAS Google Scholar
Barclay ML, Begg EJ, Chambers ST, et al. Adaptive resistance to tobramycin in Pseudomonas aeruginosa in the sputum of patients with cystic fibrosis. J Antimicrob Chemother 1996; 37: 1155–64 ArticlePubMedCAS Google Scholar
Bryan LE, Van Der Elzen HM. Gentamicin accumulation by sensitive strains of Escherichia coli and Pseudomonas aeruginosa. J Antibiot 1975; 28: 696–703 ArticlePubMedCAS Google Scholar
Hancock REW. Aminoglycoside uptake and mode of action — with special reference to streptomycin and gentamicin. I. Antagonists and mutants. II. Effects of aminoglycosides on cells. J Antimicrob Chemother 1981; 8: 429–45 ArticlePubMedCAS Google Scholar
Hancock REW, Bell A. Antibiotic uptake into Gram-negative bacteria. In: Jackson GG, editor. Perspectives in antiinfective therapy. Braunschweig (FRG): Vieweg and Sohn, 1989: 21–8 Google Scholar
Jackson GG, Lolans VT, Daikos GJ. The inductive role of ionic binding in the bactericidal and postexposure effects of aminoglycoside antibiotics with implications for dosing. J Infect Dis 1990; 162: 408–13 ArticlePubMedCAS Google Scholar
Gilbert DN. Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995: 279–306 Google Scholar
Peterson AA, Hancock REW, McGroarty EJ. Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa. J Bacteriol 1985; 164: 1256–61 PubMedCAS Google Scholar
Bryan LE, Kwan S. Roles of ribosomal binding, membrane potential and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob Agents Chemother 1983; 23: 835–45 ArticlePubMedCAS Google Scholar
Bryan LE, Van Der Elzen HM. Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Chemother 1977; 12: 163–77 ArticlePubMedCAS Google Scholar
Karlowsky JA, Hoban DJ, Zelenitsky SA, et al. Altered denA and anr gene expression in aminoglycoside adaptive resistance in Pseudomonas aeruginosa. J Antimicrob Chemother 1997; 40: 371–6 ArticlePubMedCAS Google Scholar